Latest Period
Q1 2026
Security Snapshot
MOLECULAR PARTNERS AG - Common Shares (MOLN) Institutional Ownership
CUSIP: 60853G106
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
4
Shares (Excl. Options)
3,591,372
Price
$3.97
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares
- Symbol
- MOLN on Nasdaq
- Shares outstanding
- 36,975,983
- Reported price per share
- $3.92
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 3,591,372
- Total reported value
- $14,241,970
- Portfolio coverage rank
- 0%
- Share change
- +2,859
- Value change
- +$11,202
- Number of holders
- 4
Security identity
Issuer context
Latest holder snapshot
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- MOLN - MOLECULAR PARTNERS AG - Common Shares is tracked under CUSIP 60853G106.
- 4 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 6 to 4 between Q4 2025 and Q1 2026.
- Reported value moved from $15,561,551 to $14,241,970.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 4 institutions filings for Q1 2026.
Security key
60853G106
Latest holder period
Q1 2026
13F holders
4
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
MOLN full holder history
MOLECULAR PARTNERS AG SEC filings
MOLECULAR PARTNERS AG company facts
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 60853G106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
MOLN
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11% | $17,696,249 | 4,284,806 | SUVRETTA CAPITAL MANAGEMENT, LLC | 15 Jun 2021 | |||
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5.8% | $8,020,830 | 2,144,607 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 30 Sep 2024 |
As of 31 Mar 2026, 4 institutional investors reported holding 3,591,372 shares of MOLECULAR PARTNERS AG - Common Shares (MOLN). This represents 9.7% of the company’s total 36,975,983 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
Q1 2026
Rows shown
1-20 of 20
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 3,591,372 | $14,241,970 | +$11,202 | $3.97 | 4 |
| 2025 Q4 | 3,588,513 | $15,561,551 | -$22,902 | $4.36 | 6 |
| 2025 Q3 | 3,581,480 | $13,287,291 | -$17,608 | $3.71 | 6 |
| 2025 Q2 | 3,586,226 | $13,712,923 | +$13,762 | $3.82 | 6 |
| 2025 Q1 | 3,582,606 | $14,158,038 | -$1,412 | $3.88 | 6 |
| 2024 Q4 | 3,582,970 | $17,041,735 | +$12,999,805 | $4.75 | 5 |
| 2024 Q3 | 849,236 | $4,201,691 | -$83,370 | $5.09 | 5 |
| 2024 Q2 | 860,199 | $6,183,756 | -$613,321 | $7.23 | 8 |
| 2024 Q1 | 945,699 | $3,829,491 | -$42,959 | $3.88 | 8 |
| 2023 Q4 | 956,492 | $3,906,862 | -$15,745 | $4.00 | 8 |
| 2023 Q3 | 960,448 | $3,907,242 | +$97,785 | $4.00 | 7 |
| 2023 Q2 | 929,499 | $5,726,664 | -$4,809 | $6.11 | 7 |
| 2023 Q1 | 930,313 | $5,597,356 | +$63,804 | $6.02 | 6 |
| 2022 Q4 | 919,479 | $5,989,241 | -$23,299 | $6.55 | 8 |
| 2022 Q3 | 921,787 | $6,172,000 | +$69,703 | $6.69 | 8 |
| 2022 Q2 | 878,797 | $5,935,000 | -$9,722,305 | $6.75 | 8 |
| 2022 Q1 | 1,354,636 | $27,569,000 | +$3,934,206 | $20.26 | 8 |
| 2021 Q4 | 1,161,423 | $22,356,000 | -$4,780,943 | $19.29 | 9 |
| 2021 Q3 | 1,407,964 | $27,697,000 | -$6,462,996 | $19.61 | 9 |
| 2021 Q2 | 1,716,979 | $35,145,000 | +$35,145,004 | $20.49 | 14 |